AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...
An asymptomatic male patient with definite LQTS with a normal ECG and QTc who was flagged by the AI. Photo Credit: J. Martijn Bos and Michael Ackerman. A new artificial intelligence (AI) solution ...
ROCHESTER, Minn. -- Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac ...
Inappropriate chemotherapy decisions may occur through use of a commonly used formula that overestimates the risk of a cardiac adverse event, warn researchers. Many cancer drugs carry a risk of QT ...
Background and Aim The cardiac changes in acute pancreatitis have been earlier studied but the data on their prognostic significance is limited. This study was done to determine electrocardiographic ...
Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research ...
Mayo Clinic, AliveCor develop mobile EKG device to monitor patients at risk of sudden cardiac death Researchers from Rochester, Minn.-based Mayo Clinic and AliveCor, a cardiology-focused medical ...
As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...
An artificial intelligence algorithm is able to identify patients with congenital Long QT syndrome using limited electrocardiogram data, according to an abstract published May 10 at the Heart Rhythm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results